ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa00430	Taurine and hypotaurine metabolism	3/116	16/8135	0.001382	0.2225	0.211	GADL1/FMO4/GGT5	3
KEGG	hsa01210	2-Oxocarboxylic acid metabolism	3/116	19/8135	0.002317	0.2225	0.211	ACO2/IDH3G/NAGS	3
KEGG	hsa04917	Prolactin signaling pathway	5/116	70/8135	0.00313	0.2225	0.211	SHC1/INS/STAT5A/TNFSF11/AKT3	5
KEGG	hsa04914	Progesterone-mediated oocyte maturation	6/116	102/8135	0.003272	0.2225	0.211	BUB1/ADCY8/PKMYT1/INS/ANAPC2/AKT3	6
KEGG	hsa01230	Biosynthesis of amino acids	5/116	75/8135	0.004219	0.2295	0.2176	ALDOC/ACO2/IDH3G/SDSL/NAGS	5
KEGG	hsa04072	Phospholipase D signaling pathway	7/116	148/8135	0.005117	0.232	0.2199	SHC1/ADCY8/GRM6/SPHK1/INS/PIK3R6/AKT3	7
KEGG	hsa05010	Alzheimer disease	12/116	384/8135	0.0084	0.3156	0.2992	NDUFB8/APH1A/TUBB/INS/SLC25A4/UQCRC1/EIF2S1/SLC39A11/PSMC1/GRIN2A/DVL1/AKT3	12
KEGG	hsa00410	beta-Alanine metabolism	3/116	31/8135	0.009496	0.3156	0.2992	ACADS/GADL1/CNDP2	3
KEGG	hsa05164	Influenza A	7/116	171/8135	0.01099	0.3156	0.2992	SLC25A4/IFNA10/EIF2S1/IL33/HLA-DMA/OAS2/AKT3	7
KEGG	hsa04213	Longevity regulating pathway - multiple species	4/116	62/8135	0.0116	0.3156	0.2992	HSPA2/ADCY8/INS/AKT3	4
KEGG	hsa04371	Apelin signaling pathway	6/116	139/8135	0.0143	0.3191	0.3025	ADCY8/SPHK1/PIK3R6/MYL2/ACTA2/AKT3	6
KEGG	hsa05162	Measles	6/116	139/8135	0.0143	0.3191	0.3025	HSPA2/IFNA10/EIF2S1/STAT5A/OAS2/AKT3	6
KEGG	hsa04140	Autophagy - animal	6/116	141/8135	0.01525	0.3191	0.3025	CAMKK2/ATG12/INS/EIF2S1/PRAP1/AKT3	6
KEGG	hsa05224	Breast cancer	6/116	147/8135	0.01837	0.34	0.3224	SHC1/SP1/DVL1/TNFSF11/FGF10/AKT3	6
KEGG	hsa00604	Glycosphingolipid biosynthesis - ganglio series	2/116	15/8135	0.01875	0.34	0.3224	ST8SIA5/B3GALT4	2
KEGG	hsa01200	Carbon metabolism	5/116	115/8135	0.024	0.408	0.3869	ALDOC/ACO2/ACADS/IDH3G/SDSL	5
KEGG	hsa04935	Growth hormone synthesis, secretion and action	5/116	119/8135	0.02732	0.4337	0.4112	SHC1/ADCY8/IGFALS/STAT5A/AKT3	5
KEGG	hsa04015	Rap1 signaling pathway	7/116	210/8135	0.03023	0.4337	0.4112	ADCY8/INS/RAPGEF1/GRIN2A/FGF10/F2RL3/AKT3	7
KEGG	hsa04611	Platelet activation	5/116	124/8135	0.03187	0.4337	0.4112	ROCK1/ADCY8/PIK3R6/F2RL3/AKT3	5
KEGG	hsa04022	cGMP-PKG signaling pathway	6/116	167/8135	0.03189	0.4337	0.4112	ROCK1/ADCY8/INS/SLC25A4/PIK3R6/AKT3	6
KEGG	hsa04211	Longevity regulating pathway	4/116	89/8135	0.03798	0.4757	0.451	CAMKK2/ADCY8/INS/AKT3	4
KEGG	hsa04114	Oocyte meiosis	5/116	131/8135	0.03899	0.4757	0.451	BUB1/ADCY8/PKMYT1/INS/ANAPC2	5
KEGG	hsa05020	Prion disease	8/116	273/8135	0.04094	0.4757	0.451	HSPA2/NDUFB8/TUBB/SLC25A4/UQCRC1/EIF2S1/PSMC1/GRIN2A	8
KEGG	hsa04964	Proximal tubule bicarbonate reclamation	2/116	23/8135	0.04197	0.4757	0.451	SLC25A10/SLC9A3	2
KEGG	hsa04923	Regulation of lipolysis in adipocytes	3/116	56/8135	0.04537	0.4919	0.4664	ADCY8/INS/AKT3	3
KEGG	hsa04915	Estrogen signaling pathway	5/116	138/8135	0.04702	0.4919	0.4664	HSPA2/SHC1/ADCY8/SP1/AKT3	5
KEGG	hsa00480	Glutathione metabolism	3/116	58/8135	0.0495	0.4959	0.4702	GGT5/GCLC/GSTA1	3
KEGG	hsa01522	Endocrine resistance	4/116	98/8135	0.05105	0.4959	0.4702	SHC1/ADCY8/SP1/AKT3	4
KEGG	hsa05017	Spinocerebellar ataxia	5/116	143/8135	0.05331	0.5	0.4741	SLC25A4/SP1/PSMC1/GRIN2A/AKT3	5
KEGG	hsa00650	Butanoate metabolism	2/116	28/8135	0.0599	0.502	0.476	ACADS/ACSM2A	2
KEGG	hsa05226	Gastric cancer	5/116	149/8135	0.06148	0.502	0.476	SHC1/REG4/DVL1/FGF10/AKT3	5
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	5/116	150/8135	0.06291	0.502	0.476	ADCY8/PIK3R6/MYL2/TPM2/AKT3	5
KEGG	hsa04927	Cortisol synthesis and secretion	3/116	65/8135	0.0653	0.502	0.476	ADCY8/MC2R/SP1	3
KEGG	hsa04510	Focal adhesion	6/116	201/8135	0.06718	0.502	0.476	SHC1/ROCK1/CHAD/RAPGEF1/MYL2/AKT3	6
KEGG	hsa00020	Citrate cycle (TCA cycle)	2/116	30/8135	0.06769	0.502	0.476	ACO2/IDH3G	2
KEGG	hsa01523	Antifolate resistance	2/116	30/8135	0.06769	0.502	0.476	GGH/TYMS	2
KEGG	hsa05415	Diabetic cardiomyopathy	6/116	203/8135	0.06977	0.502	0.476	NDUFB8/INS/SLC25A4/UQCRC1/SP1/AKT3	6
KEGG	hsa04932	Non-alcoholic fatty liver disease	5/116	155/8135	0.07032	0.502	0.476	NDUFB8/INS/UQCRC1/EIF2S1/AKT3	5
KEGG	hsa05160	Hepatitis C	5/116	157/8135	0.07342	0.502	0.476	CLDN15/IFNA10/EIF2S1/OAS2/AKT3	5
KEGG	hsa05014	Amyotrophic lateral sclerosis	9/116	364/8135	0.0751	0.502	0.476	NDUFB8/VCP/TUBB/UQCRC1/EIF2S1/PSMC1/GRIN2A/TPR/CHCHD10	9
KEGG	hsa05145	Toxoplasmosis	4/116	112/8135	0.07567	0.502	0.476	HSPA2/PIK3R6/HLA-DMA/AKT3	4
KEGG	hsa04630	JAK-STAT signaling pathway	5/116	162/8135	0.08148	0.5194	0.4925	IL9R/CNTFR/IFNA10/STAT5A/AKT3	5
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	6/116	212/8135	0.08212	0.5194	0.4925	ADCY8/STAT5A/TNFSF11/GSTA1/FGF10/AKT3	6
KEGG	hsa05012	Parkinson disease	7/116	266/8135	0.08533	0.5224	0.4953	NDUFB8/TUBB/SLC25A4/UQCRC1/EIF2S1/SLC39A11/PSMC1	7
KEGG	hsa04071	Sphingolipid signaling pathway	4/116	119/8135	0.08987	0.5224	0.4953	ROCK1/SPHK1/DEGS2/AKT3	4
KEGG	hsa00512	Mucin type O-glycan biosynthesis	2/116	36/8135	0.09285	0.5224	0.4953	GALNT16/GALNT8	2
KEGG	hsa05220	Chronic myeloid leukemia	3/116	76/8135	0.09414	0.5224	0.4953	SHC1/STAT5A/AKT3	3
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	6/116	222/8135	0.09719	0.5224	0.4953	ADCY8/SLC25A4/STAT5A/ANAPC2/HLA-DMA/AKT3	6
KEGG	hsa01250	Biosynthesis of nucleotide sugars	2/116	37/8135	0.09727	0.5224	0.4953	NAGK/MIOX	2
KEGG	hsa04960	Aldosterone-regulated sodium reabsorption	2/116	37/8135	0.09727	0.5224	0.4953	HSD11B2/INS	2
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	6/116	223/8135	0.09877	0.5224	0.4953	NDUFB8/SLC25A4/UQCRC1/SLC26A6/GSTA1/AKT3	6
KEGG	hsa04612	Antigen processing and presentation	3/116	78/8135	0.09987	0.5224	0.4953	HSPA2/KIR2DL3/HLA-DMA	3
KEGG	hsa04926	Relaxin signaling pathway	4/116	129/8135	0.1122	0.5724	0.5428	SHC1/ADCY8/ACTA2/AKT3	4
KEGG	hsa04014	Ras signaling pathway	6/116	232/8135	0.1136	0.5724	0.5428	SHC1/INS/PLA2G6/GRIN2A/FGF10/AKT3	6
KEGG	hsa05332	Graft-versus-host disease	2/116	42/8135	0.1202	0.586	0.5556	KIR2DL3/HLA-DMA	2
KEGG	hsa04012	ErbB signaling pathway	3/116	85/8135	0.121	0.586	0.5556	SHC1/STAT5A/AKT3	3
KEGG	hsa04270	Vascular smooth muscle contraction	4/116	134/8135	0.1242	0.586	0.5556	ROCK1/ADCY8/ACTA2/PLA2G6	4
KEGG	hsa04940	Type I diabetes mellitus	2/116	43/8135	0.125	0.586	0.5556	INS/HLA-DMA	2
KEGG	hsa04260	Cardiac muscle contraction	3/116	87/8135	0.1273	0.5868	0.5563	UQCRC1/MYL2/TPM2	3
KEGG	hsa04910	Insulin signaling pathway	4/116	137/8135	0.1317	0.5962	0.5652	SHC1/INS/RAPGEF1/AKT3	4
KEGG	hsa04976	Bile secretion	3/116	89/8135	0.1337	0.5962	0.5652	ADCY8/SLC51A/SLC9A3	3
KEGG	hsa04062	Chemokine signaling pathway	5/116	192/8135	0.1391	0.6101	0.5784	SHC1/ROCK1/ADCY8/PIK3R6/AKT3	5
KEGG	hsa00514	Other types of O-glycan biosynthesis	2/116	47/8135	0.1443	0.6232	0.5909	GALNT16/GALNT8	2
KEGG	hsa05414	Dilated cardiomyopathy	3/116	96/8135	0.157	0.6457	0.6122	ADCY8/MYL2/TPM2	3
KEGG	hsa03040	Spliceosome	4/116	147/8135	0.1578	0.6457	0.6122	HSPA2/PPIE/CTNNBL1/PRPF8	4
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	3/116	97/8135	0.1605	0.6457	0.6122	SPHK1/PLA2G6/AKT3	3
KEGG	hsa05169	Epstein-Barr virus infection	5/116	202/8135	0.1614	0.6457	0.6122	IFNA10/PSMC1/HLA-DMA/OAS2/AKT3	5
KEGG	hsa00270	Cysteine and methionine metabolism	2/116	51/8135	0.1643	0.6457	0.6122	SDSL/GCLC	2
KEGG	hsa04913	Ovarian steroidogenesis	2/116	51/8135	0.1643	0.6457	0.6122	ADCY8/INS	2
KEGG	hsa00600	Sphingolipid metabolism	2/116	52/8135	0.1694	0.6457	0.6122	SPHK1/DEGS2	2
KEGG	hsa05320	Autoimmune thyroid disease	2/116	53/8135	0.1745	0.6457	0.6122	IFNA10/HLA-DMA	2
KEGG	hsa04921	Oxytocin signaling pathway	4/116	154/8135	0.1772	0.6457	0.6122	ROCK1/CAMKK2/ADCY8/PIK3R6	4
KEGG	hsa04934	Cushing syndrome	4/116	155/8135	0.18	0.6457	0.6122	ADCY8/MC2R/SP1/DVL1	4
KEGG	hsa04150	mTOR signaling pathway	4/116	156/8135	0.1828	0.6457	0.6122	INS/NPRL2/DVL1/AKT3	4
KEGG	hsa04217	Necroptosis	4/116	159/8135	0.1915	0.6457	0.6122	SLC25A4/IFNA10/STAT5A/IL33	4
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	3/116	106/8135	0.1923	0.6457	0.6122	ADCY8/SP1/TNFSF11	3
KEGG	hsa01212	Fatty acid metabolism	2/116	57/8135	0.1951	0.6457	0.6122	ACADS/ELOVL5	2
KEGG	hsa05134	Legionellosis	2/116	57/8135	0.1951	0.6457	0.6122	HSPA2/VCP	2
KEGG	hsa03013	Nucleocytoplasmic transport	3/116	108/8135	0.1996	0.6457	0.6122	UBE2I/UPF2/TPR	3
KEGG	hsa04066	HIF-1 signaling pathway	3/116	109/8135	0.2033	0.6457	0.6122	ALDOC/INS/AKT3	3
KEGG	hsa04330	Notch signaling pathway	2/116	59/8135	0.2055	0.6457	0.6122	APH1A/DVL1	2
KEGG	hsa04370	VEGF signaling pathway	2/116	59/8135	0.2055	0.6457	0.6122	SPHK1/AKT3	2
KEGG	hsa04024	cAMP signaling pathway	5/116	221/8135	0.2076	0.6457	0.6122	ROCK1/ADCY8/MC2R/GRIN2A/AKT3	5
KEGG	hsa04978	Mineral absorption	2/116	60/8135	0.2107	0.6457	0.6122	SLC26A6/SLC9A3	2
KEGG	hsa00590	Arachidonic acid metabolism	2/116	61/8135	0.2159	0.6457	0.6122	PLA2G6/GGT5	2
KEGG	hsa05163	Human cytomegalovirus infection	5/116	225/8135	0.2178	0.6457	0.6122	ROCK1/ADCY8/IFNA10/SP1/AKT3	5
KEGG	hsa05225	Hepatocellular carcinoma	4/116	168/8135	0.2181	0.6457	0.6122	SHC1/DVL1/GSTA1/AKT3	4
KEGG	hsa04725	Cholinergic synapse	3/116	113/8135	0.2181	0.6457	0.6122	ADCY8/PIK3R6/AKT3	3
KEGG	hsa04530	Tight junction	4/116	169/8135	0.2211	0.6457	0.6122	ROCK1/CLDN15/MYL2/MICALL2	4
KEGG	hsa04670	Leukocyte transendothelial migration	3/116	114/8135	0.2218	0.6457	0.6122	ROCK1/CLDN15/MYL2	3
KEGG	hsa04724	Glutamatergic synapse	3/116	114/8135	0.2218	0.6457	0.6122	ADCY8/GRM6/GRIN2A	3
KEGG	hsa04623	Cytosolic DNA-sensing pathway	2/116	63/8135	0.2265	0.6457	0.6122	IFNA10/IL33	2
KEGG	hsa04141	Protein processing in endoplasmic reticulum	4/116	171/8135	0.2272	0.6457	0.6122	HSPA2/VCP/EIF2S1/RNF5	4
KEGG	hsa00511	Other glycan degradation	1/116	18/8135	0.228	0.6457	0.6122	AGA	1
KEGG	hsa04929	GnRH secretion	2/116	64/8135	0.2317	0.6457	0.6122	HCN3/AKT3	2
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	9/116	476/8135	0.2378	0.6457	0.6122	NDUFB8/VCP/TUBB/SLC25A4/UQCRC1/EIF2S1/PSMC1/GRIN2A/DVL1	9
KEGG	hsa04722	Neurotrophin signaling pathway	3/116	119/8135	0.2407	0.6457	0.6122	SHC1/RAPGEF1/AKT3	3
KEGG	hsa04060	Cytokine-cytokine receptor interaction	6/116	295/8135	0.2445	0.6457	0.6122	IL9R/CNTFR/IFNA10/IL33/TNFSF11/ACVRL1	6
KEGG	hsa04152	AMPK signaling pathway	3/116	120/8135	0.2446	0.6457	0.6122	CAMKK2/INS/AKT3	3
KEGG	hsa04720	Long-term potentiation	2/116	67/8135	0.2476	0.6457	0.6122	ADCY8/GRIN2A	2
KEGG	hsa05221	Acute myeloid leukemia	2/116	67/8135	0.2476	0.6457	0.6122	STAT5A/AKT3	2
KEGG	hsa00670	One carbon pool by folate	1/116	20/8135	0.2499	0.6457	0.6122	TYMS	1
KEGG	hsa05152	Tuberculosis	4/116	180/8135	0.255	0.6457	0.6122	SPHK1/IFNA10/HLA-DMA/AKT3	4
KEGG	hsa04020	Calcium signaling pathway	5/116	240/8135	0.2575	0.6457	0.6122	ADCY8/SPHK1/SLC25A4/GRIN2A/FGF10	5
KEGG	hsa04920	Adipocytokine signaling pathway	2/116	69/8135	0.2582	0.6457	0.6122	CAMKK2/AKT3	2
KEGG	hsa05211	Renal cell carcinoma	2/116	69/8135	0.2582	0.6457	0.6122	RAPGEF1/AKT3	2
KEGG	hsa00770	Pantothenate and CoA biosynthesis	1/116	21/8135	0.2606	0.6457	0.6122	GADL1	1
KEGG	hsa04622	RIG-I-like receptor signaling pathway	2/116	70/8135	0.2635	0.6457	0.6122	ATG12/IFNA10	2
KEGG	hsa04110	Cell cycle	3/116	126/8135	0.2676	0.6457	0.6122	BUB1/PKMYT1/ANAPC2	3
KEGG	hsa05016	Huntington disease	6/116	306/8135	0.271	0.6457	0.6122	NDUFB8/TUBB/SLC25A4/UQCRC1/SP1/PSMC1	6
KEGG	hsa00220	Arginine biosynthesis	1/116	22/8135	0.2712	0.6457	0.6122	NAGS	1
KEGG	hsa00340	Histidine metabolism	1/116	22/8135	0.2712	0.6457	0.6122	CNDP2	1
KEGG	hsa00982	Drug metabolism - cytochrome P450	2/116	72/8135	0.2741	0.6457	0.6122	FMO4/GSTA1	2
KEGG	hsa05218	Melanoma	2/116	72/8135	0.2741	0.6457	0.6122	FGF10/AKT3	2
KEGG	hsa05223	Non-small cell lung cancer	2/116	72/8135	0.2741	0.6457	0.6122	STAT5A/AKT3	2
KEGG	hsa04380	Osteoclast differentiation	3/116	128/8135	0.2754	0.6457	0.6122	TNFSF11/CALCR/AKT3	3
KEGG	hsa01524	Platinum drug resistance	2/116	73/8135	0.2794	0.6492	0.6155	GSTA1/AKT3	2
KEGG	hsa03430	Mismatch repair	1/116	23/8135	0.2816	0.6492	0.6155	RFC5	1
KEGG	hsa04068	FoxO signaling pathway	3/116	131/8135	0.2871	0.6507	0.6169	ATG12/INS/AKT3	3
KEGG	hsa04650	Natural killer cell mediated cytotoxicity	3/116	131/8135	0.2871	0.6507	0.6169	SHC1/KIR2DL3/IFNA10	3
KEGG	hsa05214	Glioma	2/116	75/8135	0.29	0.6508	0.6171	SHC1/AKT3	2
KEGG	hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1/116	24/8135	0.2919	0.6508	0.6171	NDST4	1
KEGG	hsa04971	Gastric acid secretion	2/116	76/8135	0.2953	0.6531	0.6192	ADCY8/ATP4A	2
KEGG	hsa00190	Oxidative phosphorylation	3/116	134/8135	0.2988	0.6554	0.6214	NDUFB8/ATP4A/UQCRC1	3
KEGG	hsa00592	alpha-Linolenic acid metabolism	1/116	25/8135	0.302	0.6572	0.6231	PLA2G6	1
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	2/116	78/8135	0.3059	0.6579	0.6238	GSTA1/AKR7A2	2
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	2/116	79/8135	0.3112	0.6579	0.6238	SHC1/AKT3	2
KEGG	hsa00790	Folate biosynthesis	1/116	26/8135	0.312	0.6579	0.6238	GGH	1
KEGG	hsa04950	Maturity onset diabetes of the young	1/116	26/8135	0.312	0.6579	0.6238	INS	1
KEGG	hsa00062	Fatty acid elongation	1/116	27/8135	0.3219	0.6632	0.6288	ELOVL5	1
KEGG	hsa01040	Biosynthesis of unsaturated fatty acids	1/116	27/8135	0.3219	0.6632	0.6288	ELOVL5	1
KEGG	hsa04966	Collecting duct acid secretion	1/116	27/8135	0.3219	0.6632	0.6288	ATP4A	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	3/116	142/8135	0.3301	0.6701	0.6353	CUL3/UBE2I/ANAPC2	3
KEGG	hsa04936	Alcoholic liver disease	3/116	142/8135	0.3301	0.6701	0.6353	CAMKK2/IFNA10/AKT3	3
KEGG	hsa04550	Signaling pathways regulating pluripotency of stem cells	3/116	143/8135	0.334	0.6703	0.6355	HOXA1/DVL1/AKT3	3
KEGG	hsa00591	Linoleic acid metabolism	1/116	29/8135	0.3411	0.6703	0.6355	PLA2G6	1
KEGG	hsa04742	Taste transduction	2/116	86/8135	0.3478	0.6703	0.6355	ADCY8/TAS2R3	2
KEGG	hsa04911	Insulin secretion	2/116	86/8135	0.3478	0.6703	0.6355	ADCY8/INS	2
KEGG	hsa00030	Pentose phosphate pathway	1/116	30/8135	0.3506	0.6703	0.6355	ALDOC	1
KEGG	hsa00053	Ascorbate and aldarate metabolism	1/116	30/8135	0.3506	0.6703	0.6355	MIOX	1
KEGG	hsa00630	Glyoxylate and dicarboxylate metabolism	1/116	30/8135	0.3506	0.6703	0.6355	ACO2	1
KEGG	hsa04540	Gap junction	2/116	88/8135	0.3582	0.6703	0.6355	ADCY8/TUBB	2
KEGG	hsa05310	Asthma	1/116	31/8135	0.3598	0.6703	0.6355	HLA-DMA	1
KEGG	hsa05417	Lipid and atherosclerosis	4/116	215/8135	0.3677	0.6703	0.6355	HSPA2/IFNA10/EIF2S1/AKT3	4
KEGG	hsa05410	Hypertrophic cardiomyopathy	2/116	90/8135	0.3685	0.6703	0.6355	MYL2/TPM2	2
KEGG	hsa00640	Propanoate metabolism	1/116	32/8135	0.369	0.6703	0.6355	ACADS	1
KEGG	hsa04136	Autophagy - other	1/116	32/8135	0.369	0.6703	0.6355	ATG12	1
KEGG	hsa04215	Apoptosis - multiple species	1/116	32/8135	0.369	0.6703	0.6355	BOK	1
KEGG	hsa01240	Biosynthesis of cofactors	3/116	153/8135	0.3731	0.6703	0.6355	NMNAT1/GGH/GCLC	3
KEGG	hsa04810	Regulation of actin cytoskeleton	4/116	218/8135	0.3775	0.6703	0.6355	ROCK1/INS/MYL2/FGF10	4
KEGG	hsa00051	Fructose and mannose metabolism	1/116	33/8135	0.378	0.6703	0.6355	ALDOC	1
KEGG	hsa04130	SNARE interactions in vesicular transport	1/116	33/8135	0.378	0.6703	0.6355	STX1B	1
KEGG	hsa04658	Th1 and Th2 cell differentiation	2/116	92/8135	0.3788	0.6703	0.6355	STAT5A/HLA-DMA	2
KEGG	hsa04970	Salivary secretion	2/116	93/8135	0.3839	0.6703	0.6355	CST3/ADCY8	2
KEGG	hsa05323	Rheumatoid arthritis	2/116	93/8135	0.3839	0.6703	0.6355	TNFSF11/HLA-DMA	2
KEGG	hsa04350	TGF-beta signaling pathway	2/116	94/8135	0.3889	0.6703	0.6355	ROCK1/SP1	2
KEGG	hsa04080	Neuroactive ligand-receptor interaction	6/116	353/8135	0.39	0.6703	0.6355	GRM6/MC2R/HCRTR2/GRIN2A/F2RL3/CALCR	6
KEGG	hsa04151	PI3K-Akt signaling pathway	6/116	354/8135	0.3926	0.6703	0.6355	INS/IFNA10/CHAD/PIK3R6/FGF10/AKT3	6
KEGG	hsa04713	Circadian entrainment	2/116	97/8135	0.4041	0.6703	0.6355	ADCY8/GRIN2A	2
KEGG	hsa05215	Prostate cancer	2/116	97/8135	0.4041	0.6703	0.6355	INS/AKT3	2
KEGG	hsa00760	Nicotinate and nicotinamide metabolism	1/116	36/8135	0.4044	0.6703	0.6355	NMNAT1	1
KEGG	hsa03030	DNA replication	1/116	36/8135	0.4044	0.6703	0.6355	RFC5	1
KEGG	hsa05161	Hepatitis B	3/116	162/8135	0.408	0.6703	0.6355	IFNA10/STAT5A/AKT3	3
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/116	98/8135	0.4091	0.6703	0.6355	ADCY8/PLA2G6	2
KEGG	hsa04925	Aldosterone synthesis and secretion	2/116	98/8135	0.4091	0.6703	0.6355	ADCY8/MC2R	2
KEGG	hsa05231	Choline metabolism in cancer	2/116	98/8135	0.4091	0.6703	0.6355	SP1/AKT3	2
KEGG	hsa05216	Thyroid cancer	1/116	37/8135	0.4129	0.6703	0.6355	TPR	1
KEGG	hsa04640	Hematopoietic cell lineage	2/116	99/8135	0.4141	0.6703	0.6355	IL9R/HLA-DMA	2
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	2/116	100/8135	0.419	0.6703	0.6355	STAT5A/AKT3	2
KEGG	hsa05330	Allograft rejection	1/116	38/8135	0.4213	0.6703	0.6355	HLA-DMA	1
KEGG	hsa04714	Thermogenesis	4/116	232/8135	0.4229	0.6703	0.6355	ADCY8/NDUFB8/UQCRC1/COX14	4
KEGG	hsa04916	Melanogenesis	2/116	101/8135	0.424	0.6703	0.6355	ADCY8/DVL1	2
KEGG	hsa04972	Pancreatic secretion	2/116	102/8135	0.4289	0.6703	0.6355	ADCY8/CLCA1	2
KEGG	hsa04974	Protein digestion and absorption	2/116	103/8135	0.4338	0.6703	0.6355	MEP1A/SLC9A3	2
KEGG	hsa00260	Glycine, serine and threonine metabolism	1/116	40/8135	0.4378	0.6703	0.6355	SDSL	1
KEGG	hsa05033	Nicotine addiction	1/116	40/8135	0.4378	0.6703	0.6355	GRIN2A	1
KEGG	hsa04064	NF-kappa B signaling pathway	2/116	104/8135	0.4386	0.6703	0.6355	UBE2I/TNFSF11	2
KEGG	hsa04620	Toll-like receptor signaling pathway	2/116	104/8135	0.4386	0.6703	0.6355	IFNA10/AKT3	2
KEGG	hsa03440	Homologous recombination	1/116	41/8135	0.4458	0.6737	0.6388	BARD1	1
KEGG	hsa04216	Ferroptosis	1/116	41/8135	0.4458	0.6737	0.6388	GCLC	1
KEGG	hsa04659	Th17 cell differentiation	2/116	108/8135	0.4579	0.6824	0.647	STAT5A/HLA-DMA	2
KEGG	hsa04931	Insulin resistance	2/116	108/8135	0.4579	0.6824	0.647	INS/AKT3	2
KEGG	hsa00071	Fatty acid degradation	1/116	43/8135	0.4616	0.6824	0.647	ACADS	1
KEGG	hsa04975	Fat digestion and absorption	1/116	43/8135	0.4616	0.6824	0.647	CLPS	1
KEGG	hsa05131	Shigellosis	4/116	247/8135	0.4706	0.6919	0.6561	ROCK1/ATG12/MYL2/AKT3	4
KEGG	hsa05132	Salmonella infection	4/116	249/8135	0.4769	0.6974	0.6612	FHOD1/TUBB/MYL2/AKT3	4
KEGG	hsa03050	Proteasome	1/116	46/8135	0.4844	0.6991	0.6628	PSMC1	1
KEGG	hsa04930	Type II diabetes mellitus	1/116	46/8135	0.4844	0.6991	0.6628	INS	1
KEGG	hsa04621	NOD-like receptor signaling pathway	3/116	184/8135	0.4904	0.6991	0.6628	ATG12/IFNA10/OAS2	3
KEGG	hsa03420	Nucleotide excision repair	1/116	47/8135	0.4918	0.6991	0.6628	RFC5	1
KEGG	hsa04973	Carbohydrate digestion and absorption	1/116	47/8135	0.4918	0.6991	0.6628	AKT3	1
KEGG	hsa00280	Valine, leucine and isoleucine degradation	1/116	48/8135	0.4991	0.6991	0.6628	ACADS	1
KEGG	hsa05034	Alcoholism	3/116	187/8135	0.5012	0.6991	0.6628	SHC1/CAMKK2/GRIN2A	3
KEGG	hsa00520	Amino sugar and nucleotide sugar metabolism	1/116	49/8135	0.5063	0.6991	0.6628	NAGK	1
KEGG	hsa00565	Ether lipid metabolism	1/116	49/8135	0.5063	0.6991	0.6628	PLA2G6	1
KEGG	hsa04672	Intestinal immune network for IgA production	1/116	49/8135	0.5063	0.6991	0.6628	HLA-DMA	1
KEGG	hsa05030	Cocaine addiction	1/116	49/8135	0.5063	0.6991	0.6628	GRIN2A	1
KEGG	hsa05165	Human papillomavirus infection	5/116	331/8135	0.5127	0.7017	0.6653	IFNA10/CHAD/PSMC1/DVL1/AKT3	5
KEGG	hsa05110	Vibrio cholerae infection	1/116	50/8135	0.5134	0.7017	0.6653	KDELR2	1
KEGG	hsa00330	Arginine and proline metabolism	1/116	51/8135	0.5204	0.7077	0.671	CNDP2	1
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	3/116	194/8135	0.526	0.7118	0.6749	IFNA10/PIK3R6/AKT3	3
KEGG	hsa05130	Pathogenic Escherichia coli infection	3/116	197/8135	0.5364	0.7223	0.6849	ROCK1/CLDN15/TUBB	3
KEGG	hsa04340	Hedgehog signaling pathway	1/116	56/8135	0.5538	0.7421	0.7036	CUL3	1
KEGG	hsa04728	Dopaminergic synapse	2/116	132/8135	0.565	0.748	0.7093	GRIN2A/AKT3	2
KEGG	hsa00240	Pyrimidine metabolism	1/116	58/8135	0.5665	0.748	0.7093	TYMS	1
KEGG	hsa05213	Endometrial cancer	1/116	58/8135	0.5665	0.748	0.7093	AKT3	1
KEGG	hsa05416	Viral myocarditis	1/116	60/8135	0.5789	0.7511	0.7121	HLA-DMA	1
KEGG	hsa04210	Apoptosis	2/116	136/8135	0.5814	0.7511	0.7121	EIF2S1/AKT3	2
KEGG	hsa05322	Systemic lupus erythematosus	2/116	136/8135	0.5814	0.7511	0.7121	GRIN2A/HLA-DMA	2
KEGG	hsa00140	Steroid hormone biosynthesis	1/116	61/8135	0.5849	0.7511	0.7121	HSD11B2	1
KEGG	hsa00561	Glycerolipid metabolism	1/116	61/8135	0.5849	0.7511	0.7121	MOGAT1	1
KEGG	hsa05135	Yersinia infection	2/116	137/8135	0.5854	0.7511	0.7121	ROCK1/AKT3	2
KEGG	hsa05418	Fluid shear stress and atherosclerosis	2/116	139/8135	0.5933	0.755	0.7159	GSTA1/AKT3	2
KEGG	hsa00310	Lysine degradation	1/116	63/8135	0.5968	0.755	0.7159	PLOD1	1
KEGG	hsa05217	Basal cell carcinoma	1/116	63/8135	0.5968	0.755	0.7159	DVL1	1
KEGG	hsa05321	Inflammatory bowel disease	1/116	65/8135	0.6083	0.7631	0.7235	HLA-DMA	1
KEGG	hsa04010	MAPK signaling pathway	4/116	294/8135	0.6088	0.7631	0.7235	HSPA2/INS/FGF10/AKT3	4
KEGG	hsa00970	Aminoacyl-tRNA biosynthesis	1/116	66/8135	0.6139	0.7632	0.7237	FARS2	1
KEGG	hsa00010	Glycolysis / Gluconeogenesis	1/116	67/8135	0.6195	0.7632	0.7237	ALDOC	1
KEGG	hsa04664	Fc epsilon RI signaling pathway	1/116	68/8135	0.6249	0.7632	0.7237	AKT3	1
KEGG	hsa04723	Retrograde endocannabinoid signaling	2/116	148/8135	0.6277	0.7632	0.7237	ADCY8/NDUFB8	2
KEGG	hsa04924	Renin secretion	1/116	69/8135	0.6303	0.7632	0.7237	CLCA1	1
KEGG	hsa05031	Amphetamine addiction	1/116	69/8135	0.6303	0.7632	0.7237	GRIN2A	1
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	1/116	69/8135	0.6303	0.7632	0.7237	GSTA1	1
KEGG	hsa04514	Cell adhesion molecules	2/116	149/8135	0.6314	0.7632	0.7237	CLDN15/HLA-DMA	2
KEGG	hsa05230	Central carbon metabolism in cancer	1/116	70/8135	0.6357	0.765	0.7254	AKT3	1
KEGG	hsa04145	Phagosome	2/116	152/8135	0.6422	0.7695	0.7296	TUBB/HLA-DMA	2
KEGG	hsa04137	Mitophagy - animal	1/116	72/8135	0.6461	0.7707	0.7308	SP1	1
KEGG	hsa00562	Inositol phosphate metabolism	1/116	73/8135	0.6512	0.7734	0.7333	MIOX	1
KEGG	hsa04218	Cellular senescence	2/116	156/8135	0.6563	0.7751	0.7349	SLC25A4/AKT3	2
KEGG	hsa03320	PPAR signaling pathway	1/116	75/8135	0.6611	0.7751	0.7349	FABP6	1
KEGG	hsa04918	Thyroid hormone synthesis	1/116	75/8135	0.6611	0.7751	0.7349	ADCY8	1
KEGG	hsa05212	Pancreatic cancer	1/116	76/8135	0.666	0.7764	0.7362	AKT3	1
KEGG	hsa05100	Bacterial invasion of epithelial cells	1/116	77/8135	0.6708	0.7764	0.7362	SHC1	1
KEGG	hsa05140	Leishmaniasis	1/116	77/8135	0.6708	0.7764	0.7362	HLA-DMA	1
KEGG	hsa04721	Synaptic vesicle cycle	1/116	78/8135	0.6755	0.7786	0.7382	STX1B	1
KEGG	hsa00983	Drug metabolism - other enzymes	1/116	80/8135	0.6848	0.786	0.7452	GSTA1	1
KEGG	hsa04662	B cell receptor signaling pathway	1/116	82/8135	0.6938	0.793	0.7518	AKT3	1
KEGG	hsa01232	Nucleotide metabolism	1/116	85/8135	0.7069	0.8011	0.7596	TYMS	1
KEGG	hsa04610	Complement and coagulation cascades	1/116	85/8135	0.7069	0.8011	0.7596	F2RL3	1
KEGG	hsa05210	Colorectal cancer	1/116	86/8135	0.7111	0.8026	0.761	AKT3	1
KEGG	hsa05168	Herpes simplex virus 1 infection	6/116	495/8135	0.7167	0.8031	0.7615	IFNA10/EIF2S1/HLA-DMA/ZNF623/OAS2/AKT3	6
KEGG	hsa04512	ECM-receptor interaction	1/116	88/8135	0.7194	0.8031	0.7615	CHAD	1
KEGG	hsa04727	GABAergic synapse	1/116	89/8135	0.7234	0.8031	0.7615	ADCY8	1
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/116	89/8135	0.7234	0.8031	0.7615	AKT3	1
KEGG	hsa05032	Morphine addiction	1/116	91/8135	0.7313	0.8086	0.7667	ADCY8	1
KEGG	hsa05222	Small cell lung cancer	1/116	92/8135	0.7352	0.8096	0.7676	AKT3	1
KEGG	hsa04912	GnRH signaling pathway	1/116	93/8135	0.739	0.8105	0.7685	ADCY8	1
KEGG	hsa05150	Staphylococcus aureus infection	1/116	96/8135	0.7502	0.8191	0.7766	HLA-DMA	1
KEGG	hsa03015	mRNA surveillance pathway	1/116	97/8135	0.7538	0.8191	0.7766	UPF2	1
KEGG	hsa00564	Glycerophospholipid metabolism	1/116	98/8135	0.7573	0.8191	0.7766	PLA2G6	1
KEGG	hsa04613	Neutrophil extracellular trap formation	2/116	190/8135	0.7588	0.8191	0.7766	SLC25A4/AKT3	2
KEGG	hsa05142	Chagas disease	1/116	102/8135	0.771	0.8289	0.7859	AKT3	1
KEGG	hsa04625	C-type lectin receptor signaling pathway	1/116	104/8135	0.7776	0.8294	0.7864	AKT3	1
KEGG	hsa04660	T cell receptor signaling pathway	1/116	104/8135	0.7776	0.8294	0.7864	AKT3	1
KEGG	hsa04922	Glucagon signaling pathway	1/116	107/8135	0.7871	0.835	0.7917	AKT3	1
KEGG	hsa05203	Viral carcinogenesis	2/116	204/8135	0.7928	0.835	0.7917	STAT5A/PSMC1	2
KEGG	hsa03008	Ribosome biogenesis in eukaryotes	1/116	109/8135	0.7932	0.835	0.7917	POP1	1
KEGG	hsa05205	Proteoglycans in cancer	2/116	205/8135	0.7951	0.835	0.7917	ROCK1/AKT3	2
KEGG	hsa04668	TNF signaling pathway	1/116	112/8135	0.802	0.8391	0.7955	AKT3	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	2/116	212/8135	0.8103	0.8444	0.8006	IFNA10/AKT3	2
KEGG	hsa05206	MicroRNAs in cancer	3/116	310/8135	0.8248	0.8547	0.8103	SHC1/ROCK1/UBE2I	3
KEGG	hsa04919	Thyroid hormone signaling pathway	1/116	121/8135	0.8264	0.8547	0.8103	AKT3	1
KEGG	hsa00230	Purine metabolism	1/116	128/8135	0.8432	0.8688	0.8237	ADCY8	1
KEGG	hsa05171	Coronavirus disease - COVID-19	2/116	232/8135	0.8484	0.8708	0.8256	IFNA10/OAS2	2
KEGG	hsa04142	Lysosome	1/116	132/8135	0.8521	0.8713	0.8262	AGA	1
KEGG	hsa04390	Hippo signaling pathway	1/116	157/8135	0.8974	0.9123	0.865	DVL1	1
KEGG	hsa03010	Ribosome	1/116	158/8135	0.8989	0.9123	0.865	MRPL16	1
KEGG	hsa04310	Wnt signaling pathway	1/116	167/8135	0.9114	0.9215	0.8738	DVL1	1
KEGG	hsa04360	Axon guidance	1/116	182/8135	0.9289	0.9358	0.8873	ROCK1	1
KEGG	hsa05202	Transcriptional misregulation in cancer	1/116	193/8135	0.9395	0.943	0.8941	SP1	1
KEGG	hsa04144	Endocytosis	1/116	251/8135	0.9743	0.9743	0.9238	HSPA2	1